Skip to content

Assess Veinplicity Venous Access Device Safety and Effectiveness

A Prospective, Single Center, Randomized, Cross-over Clinical Trial to Assess the Safety and Effectiveness of the Veinplicity Venous Access Device

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03109405
Enrollment
200
Registered
2017-04-12
Start date
2015-06-30
Completion date
2015-08-31
Last updated
2018-04-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Phlebotomy

Brief summary

The purpose of this study was to examine the Veinplicity Device as an adjunctive IV cannulation tool in subjects with a history of difficult to access veins. The Veinplicity Device is intended to improve venous access rates in compromised patients by taking advantage of the increased circulation that results from provoked muscle stimulation. The study collected information about the device, intravenous access, user and patient perceptions for IV access, and any device or procedural complications or other adverse events. Device use was examined with patients in both a prone and upright position.

Interventions

DEVICEStimulation-assisted venous access

Stimulation-assisted venous access

OTHER20 guage cannula for IV, tourniquet optional

Standard IV cannulation using 20 ga needle, and use of tourniquet at discretion of nurse performing IV cannulation

Sponsors

Physeon GmbH
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Subject ≥ 18 years of age * Subject with history of failed venous access, venipuncture, or IV cannula placement * Subject agreed to required follow-up * Subject provided written, informed consent

Exclusion criteria

* Subject currently had compromised skin on either forearm or hand * Subject currently on any blood thinning medication other than 81mg of aspirin * Subject had been diagnosed with peripheral neuropathy, has had a complex fracture or surgery in the forearm, or has other condition that diminishes sensation in one or both arms, hands or fingers * Subject had a demand type pacemaker or defibrillator * Subject is female of child-bearing potential and had a positive urine pregnancy test * Subject had a history of seizure, convulsions or epilepsy * Subject had a known allergy to Epsom salts * Subject had any other condition that may affect the ability to complete study requirements

Design outcomes

Primary

MeasureTime frame
Rate of successful venous access on the first attempt.7 days
Rate of adverse events associated with either the treatment or the venous access site.7 days

Secondary

MeasureTime frameDescription
User Perception of IV cannulation difficulty,7 days
Subject Perception of Device stimulation7 days
Number of attempts required to achieve successful IV cannula placementover a 24 hour periodnumber of punctures from initial puncture to successful IV cannulation
Subject Preception of IV cannulation pain7 days
Time required to achieve successful IV cannula placementtime from initial puncture to successful IV cannulation

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026